Method of Detecting Cystic Fibrosis Associated Mutations

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20080138803A1
SERIAL NO

11628194

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention describes a method for the simultaneous identification of two or more single base changes, insertions, deletions or translocations in a plurality of target nucleotide sequences that are markers associated with cystic fibrosis. Multiplex detection is accomplished using multiplexed tagged allele specific primer extension (ASPE) and hybridization of such extended primers to a probe, preferably an addressable anti-tagged support.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
LUMINEX MOLECULAR DIAGNOSTICS INC439 UNIVERSITY AVENUE SUITE 1710 TORONTO ONTARIO M5G 1Y8

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Barbara, Etobicoke, CA 1 31
Galvan-Goldman, nee Galvan 1 31
Lisle, Connie Ancaster, CA 1 31

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation